Itolizumab For Injection
Itolizumab is said to be the first new biologic therapy approved globally for the treatment of moderate to severe Covid-19 complications. The drug is an anti-CD6 IgG1 monoclonal antibody introduced in India in 2013 under the brand name ALZUMAb to treat chronic plaque psoriasis.